ICON Public Limited Company Total Inventories 2011-2026 | ICLR

Annual Total Inventories ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	2.3 M	2.2 M	2.4 M	1.8 M	1.7 M	2.2 M	3 M	2.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3 M	1.7 M	2.3 M

Quarterly Total Inventories ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	5.8 M	-	-	-	4.8 M	-	-	-	3.2 M	-	-	-	2.3 M	-	-	-	2.2 M	-	-	-	2.4 M	-	-	-	1.8 M	-	-	-	1.7 M	-	-	-	2.2 M	-	-	-	3 M	-	-	-	2.8 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.8 M	1.7 M	2.93 M

Total Inventories of other stocks in the Diagnostics research industry

Issuer	Total Inventories	Price	% 24h	Market Cap	Country
Agilent Technologies A	830 M	$ 117.5	2.1 %	$ 35.7 B	USA
Aspira Women's Health AWH	256 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	757 K	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	7.72 M	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	1 M	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	26.7 M	$ 16.83	4.86 %	$ 897 M	USA
Exact Sciences Corporation EXAS	166 M	-	-	$ 19.8 B	USA
Enzo Biochem ENZ	6.83 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	992 K	$ 1.45	5.84 %	$ 1.93 M	USA
Accelerate Diagnostics AXDX	5.19 M	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	8.14 M	$ 23.53	1.73 %	$ 654 M	USA
Global Cord Blood Corporation CO	45.9 M	-	-	$ 399 M	China
Charles River Laboratories International CRL	299 M	$ 178.34	1.53 %	$ 8.84 B	USA
Interpace Biosciences IDXG	1.11 M	$ 2.2	-4.35 %	$ 9.73 M	USA
Danaher Corporation DHR	2.49 B	$ 195.87	3.3 %	$ 140 B	USA
Heska Corporation HSKA	60 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	909 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	547 M	$ 126.96	4.99 %	$ 20.2 B	USA
Guardant Health GH	85.9 M	$ 82.21	4.59 %	$ 10.3 B	USA
QIAGEN N.V. QGEN	302 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	1.49 M	$ 2.08	-2.8 %	$ 4.78 M	USA
Laboratory Corporation of America Holdings LH	535 M	$ 264.18	1.25 %	$ 22 B	USA
Myriad Genetics MYGN	30.6 M	$ 4.59	5.52 %	$ 425 M	USA
NeoGenomics NEO	28.6 M	$ 8.0	4.03 %	$ 1.02 B	USA
Neogen Corporation NEOG	191 M	$ 9.14	-2.97 %	$ 1.98 B	USA
Lantheus Holdings LNTH	64.7 M	$ 81.67	1.34 %	$ 5.51 B	USA
Motus GI Holdings MOTS	496 K	-	-34.28 %	$ 263 K	Israel
Natera NTRA	35.4 M	$ 201.9	4.6 %	$ 19.9 B	USA
Invitae Corporation NVTA	30.4 M	-	-	$ 21.2 M	USA
Quest Diagnostics Incorporated DGX	189 M	$ 192.91	0.73 %	$ 21.4 B	USA
ENDRA Life Sciences NDRA	2.62 M	$ 5.19	5.06 %	$ 4.08 M	USA
Organovo Holdings ONVO	297 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	3.65 M	-	-16.95 %	$ 1.54 M	USA
Pacific Biosciences of California PACB	49.3 M	$ 1.45	8.21 %	$ 435 M	USA